Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. Februar 2008 08:00 ET | Quelle: Tracon Pharmaceuticals

Ireland Cancer Center and TRACON Pharmaceuticals Announce Treating the First Cancer Patient With TRC102, An Inhibitor of Chemotherapy Resistance

CLEVELAND and SAN DIEGO, Feb. 25, 2008 (PRIME NEWSWIRE) -- The Ireland Cancer Center of University Hospitals Case Medical Center and TRACON Pharmaceuticals, Inc. announced that the first cancer...
09. Januar 2008 08:00 ET | Quelle: Tracon Pharmaceuticals

TRACON Pharmaceuticals Announces Dosing of Initial Three Cancer Patients in a Phase 1 Clinical Trial With TRC105, a Human Chimeric Antibody

SAN DIEGO, Jan. 9, 2008 (PRIME NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (TRACON), a privately-held biopharmaceutical company focused on the development of products for oncology and ophthalmology...
02. November 2007 14:46 ET | Quelle: Tracon Pharmaceuticals

TRACON Pharmaceuticals to Present At the Rodman & Renshaw 9th Annual Healthcare Conference

SAN DIEGO, Nov. 2, 2007 (PRIME NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (TRACON), a biopharmaceutical company focused on the development of products for oncology and ophthalmology treatment, today...